Bio-Path Holdings
BPTH
BPTH was delisted on the 18th of February, 2025.
48 hedge funds and large institutions have $26.7M invested in Bio-Path Holdings in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.
220% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 5
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
12% more funds holding
Funds holding: 43 → 48 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.6% less ownership
Funds ownership: 21.32% → 20.72% (-0.6%)
27% less capital inflows, than outflows
Capital inflows: $2.17M | Capital outflows: $2.96M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$615K |
| 2 |
BlackRock Fund Advisors
San Francisco,
California
|
+$460K |
| 3 |
Morgan Stanley
New York
|
+$291K |
| 4 |
JP Morgan Chase
New York
|
+$145K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$140K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$1.45M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$790K |
| 3 |
CWM
Concert Wealth Management
San Jose,
California
|
-$424K |
| 4 |
Panagora Asset Management
Boston,
Massachusetts
|
-$145K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$87K |
BPTH Hedge Fund Activity: Q4 2016 in Review
48 of the 4,007 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings (BPTH) for Q4 2016, worth a combined $26.7M — down 6.3% from $28.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BPTH positions and 5 closed out — a net gain of 4 holders — while 16 added to existing stakes and 5 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $615K. The largest seller was Raymond James Financial Services Advisors, cutting an estimated $1.45M.
- 48 institutional investors held Bio-Path Holdings (BPTH) as of Q4 2016, up from 43 in Q3 2016.
- Funds reported $26.7M of Bio-Path Holdings stock for Q4 2016, down 6.3% quarter-over-quarter.
- 9 funds opened new Bio-Path Holdings positions in Q4 2016 and 5 closed out, a net change of +4 holders.
- The largest Bio-Path Holdings buyer in Q4 2016 was Millennium Management, an estimated $615K added.
- The largest Bio-Path Holdings seller in Q4 2016 was Raymond James Financial Services Advisors, an estimated $1.45M sold.
Based on aggregated 13F filings for Q4 2016.